Edap Tms (NASDAQ:EDAP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

Other research analysts have also recently issued reports about the stock. HC Wainwright restated a “buy” rating and issued a $19.00 price objective on shares of Edap Tms in a research report on Friday, March 28th. Jefferies Financial Group reissued a “hold” rating and issued a $2.00 price target (down previously from $8.00) on shares of Edap Tms in a report on Friday. Finally, Piper Sandler dropped their price objective on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a report on Friday, March 28th.

Edap Tms Price Performance

Shares of NASDAQ:EDAP opened at $1.45 on Friday. The company has a 50 day moving average of $2.37 and a 200 day moving average of $2.44. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The stock has a market cap of $53.80 million, a P/E ratio of -2.23 and a beta of 0.12. Edap Tms has a 12 month low of $1.40 and a 12 month high of $8.50.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.06. The firm had revenue of $22.69 million for the quarter, compared to analysts’ expectations of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. As a group, sell-side analysts forecast that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of EDAP. Rock Springs Capital Management LP boosted its stake in shares of Edap Tms by 1.5% in the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock valued at $3,518,000 after purchasing an additional 23,800 shares in the last quarter. Schonfeld Strategic Advisors LLC boosted its position in Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after buying an additional 52,500 shares during the period. Orion Capital Management LLC grew its stake in shares of Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 33,558 shares during the period. Finally, BNP Paribas Financial Markets lifted its stake in shares of Edap Tms by 111.5% in the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares during the last quarter. 62.74% of the stock is currently owned by institutional investors.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.